The scientific focus of TheRNAtik is to provide expertise in the application and better understanding of RNA-based immunotherapies for the treatment of tumors and immune-mediated diseases. Particular attention is paid to the following topics:
RNA-based vaccines for cancer immunotherapy
RNA-based vaccines to combat infectious diseases
RNA-based vaccines for the treatment of allergies and autoimmune diseases
Protein replacement therapies in immune-mediated diseases
RNA-mediated reprogramming of immune cells for the treatment of tumors and immune-mediated diseases
Genome editing by RNA-encoded nucleases in immune cells.